The Top Line A closer look at European biotech investment in 2024
4 snips
Mar 22, 2024 Maina Bhaman, Partner at Sofinnova Capital Strategy, discusses European biotech investment trends, highlighting investor loyalty in 2023 and prospects for biotech IPOs. Insights include the growth of European biotech post-pandemic, challenges in attracting investors, and the importance of US presence for global expansion.
Chapters
Transcript
Episode notes
1 2 3 4 5
Introduction
00:00 • 2min
Exploring European Biotech Investment and Saffinova Partners' Diversification
01:37 • 2min
European Biotech Investment: Growth and Evolution
03:19 • 7min
Importance of European Biotechs Having a US Presence for Global Growth
10:04 • 2min
European Biotech Investment Trends
11:35 • 7min